zepbound is semaglutide beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs – Zepbound vs. Wegovy: Which Weight

Cross-check FDA warning letters at fda.gov against the pharmacy and its parent company

In the United States, patients will need to wait until at least 2031 before seeing generic versions of semaglutide medications

This isnt just a theoretical issueboth Novo Nordisk, the maker of Ozempic and Wegovy, and Eli Lilly, the maker of Mounjaro, have filed lawsuits against medical spas and compounding pharmacies alleging that they engaged in false or misleading advertising related to their drugs

When paired with a nutritious diet and regular exercise, semaglutide supports fat loss while helping to maintain lean muscle mass